United Nations and Ethiopia reach aid pact for war-hit Tigray    Arsenal's Arteta expects difficult January transfer window    Wolves' Jimenez recovering well from surgery on fractured skull    Chelsea win Group E as Giroud scores 4 goals vs Sevilla    Khartoum's benefits from GERD cannot be achieved without signature of a binding legal agreement, says Sudan's irrigation minister    In Photos: Egypt's Sisi inspects a number of locally-manufactured multi-use vehicle models    Egypt's stock market slightly up, main index falls after Juhayna head arrest    42nd Cairo International Film Festival opens today amid strict precautionary measures    Not so Merry Christmas looms for coronavirus-hit Europe    Asian stocks mixed on Wednesday after Wall Street surged overnight    Armed bank robbers storm another Brazilian town, battle police in streets    UK approves Pfizer-BioNTech Coronavirus vaccine, first in the world    Deadline for reconciliation requests in building violations pushed back till end of 2020: Egypt cabinet    Egypt confirms 392 new coronavirus cases, 16 deaths on Tuesday    Egypt's capital inflows fell by half in FY2019/20, CBE    Iran's president rejects bill that would boost enrichment    Egyptian expats to print ballots starting Thursday for 2nd stage of parliamentary run-offs    In '76 Days,' a documentary portrait of lockdown in Wuhan    Eni reaches agreements with Egypt, Naturgy to restart operations at gas plant in Damietta    Gana Hena play at Al-Ghad Theatre is a must go    A final battle    Free Devastation    France aiming for broader COVID-19 vaccination campaign in spring: Macron    Egypt reports 370 new coronavirus cases, 14 deaths on Monday    Brexit unresolved, as EU, UK say big differences remain    Cairo International Book Fair suspended for five months over coronavirus concerns    US will reduce number of its troop in Iraq, Afghanistan    Asia forms world's biggest trade bloc, a China-backed group excluding U.S    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    1st stage of Egypt's parliamentary elections kicks off on Saturday    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    Legend footballer Lionel Messi says he is forced to stay with Barcelona    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Iraqi conglomerate eyes developing land that housed Mubarak-era ruling party HQ    Legend Messi officially wants to leave Barcelona, hands transfer request    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT
Published in Ahram Online on 26 - 10 - 2020

The COVID-19 vaccine being developed by the University of Oxford and AstraZeneca Plc produces a robust immune response in elderly people, the group at highest risk, the Financial Times said on Monday, citing early results.
The vaccine triggers protective antibodies and T-cells in older age groups, the FT said https://on.ft.com/3kxKyJI, citing two people familiar with the finding, encouraging researchers as they seek evidence that it will spare those in later life from serious illness or death from the virus.
Details of the finding are expected to be published shortly in a clinical journal, the FT said, without naming the publication.
The findings echo data released in July which showed the vaccine generated "robust immune responses" in a group of healthy adults aged between 18 and 55, the newspaper reported, citing people aware of the results from so-called immunogenicity blood tests.
But the FT cautioned that positive immunogenicity tests do not guarantee that the vaccine will ultimately prove safe and effective in older people.
AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a vaccine to protect against COVID-19.
Oxford and AstraZeneca did not immediately respond to Reuters' request for comments.
One of the world's leading coronavirus vaccine candidates, called AZD1222 or ChAdOx1 nCoV-19, was developed by Oxford University scientists and licensed to AstraZeneca in April, which took on the task of scaling trials and production.
AstraZeneca resumed the U.S. trial of the experimental vaccine after approval by U.S. regulators, the company said on Friday.
It is a viral vector vaccine that uses a weakened version of a chimpanzee common cold virus that encodes instructions for making proteins from the novel coronavirus to build immunity against COVID-19.


Clic here to read the story from its source.